• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于植物提取物和可生物降解聚合物的几种纳米制剂的制备及初步分析,作为慢性静脉疾病治疗的一种可能应用

Preparation and Preliminary Analysis of Several Nanoformulations Based on Plant Extracts and Biodegradable Polymers as a Possible Application for Chronic Venous Disease Therapy.

作者信息

Ungureanu Andreea Roxana, Ozon Emma Adriana, Musuc Adina Magdalena, Anastasescu Mihai, Atkinson Irina, Mitran Raul-Augustin, Rusu Adriana, Popescu Liliana, Gîrd Cerasela Elena

机构信息

Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, 6 Traian Vuia Street, 020956 Bucharest, Romania.

Institute of Physical Chemistry-Ilie Murgulescu, Romanian Academy, 202 Splaiul Independenței, 060021 Bucharest, Romania.

出版信息

Polymers (Basel). 2024 May 10;16(10):1362. doi: 10.3390/polym16101362.

DOI:10.3390/polym16101362
PMID:38794552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11125073/
Abstract

Nanotechnology is one of the newest directions for plant-based therapies. Chronic venous disease often predisposes to long-term and invasive treatment. This research focused on the inclusion of vegetal extracts from (SE), (CE), and (GE) in formulations with PHB and PLGA polymers and their physicochemical characterization as a preliminary stage for possible use in the development of a complex therapeutic product. The samples were prepared by an oil-water emulsification and solvent evaporation technique, resulting in suspensions with high spreadability and a pH of 5.5. ATR-FTIR analysis revealed bands for stretching vibrations (O-H, C=O, and C-H in symmetric and asymmetric methyl and methylene) in the same regions as the base components, but switched to high or low wavenumbers and absorbance, highlighting the formation of adducts/complexes between the extracts and polymers. The obtained formulations were in the amorphous phase, as confirmed by XRD analysis. AFM analysis emphasized the morphological peculiarities of the extract-polymer nanoformulations. It could be noticed that, in the case of SE-based formulations, the dominant characteristics for SE-PHB and SE-PLGA composition were the formation of random large (SE-PHB) and smaller uniform (SE-PLGA) particles; further on, these particles tended to aggregate in the case of SE-PHB-PLGA. For the CE- and GE-based formulations, the dominant surface morphology was their porosity, generally with small pores, but larger cavities were observed in some cases (CE- and GE-PHB). The highest roughness values at the (8 µm × 8 μm) scale were found for the following samples and succession: CE-PHB < SE-PLGA < SE-PHB-PLGA. In addition, by thermogravimetric analysis, impregnation in the matrix of compression stockings was evaluated, which varied in the following order: CE-polymer > SE-polymer > GE-polymer. In conclusion, nine vegetal extract-polymer nanoformulations were prepared and preliminarily characterized (by advanced physicochemical methods) as a starting point for further optimization, stability studies, and possible use in complex pharmaceutical products.

摘要

纳米技术是植物疗法的最新发展方向之一。慢性静脉疾病常常需要长期且侵入性的治疗。本研究聚焦于将来自[具体植物1](SE)、[具体植物2](CE)和[具体植物3](GE)的植物提取物与聚羟基丁酸酯(PHB)和聚乳酸-羟基乙酸共聚物(PLGA)聚合物混合制成制剂,并对其进行物理化学表征,作为开发复杂治疗产品的初步阶段。样品通过油水乳化和溶剂蒸发技术制备,得到具有高铺展性且pH值为5.5的悬浮液。衰减全反射傅里叶变换红外光谱(ATR-FTIR)分析显示,在与基础成分相同的区域出现了拉伸振动谱带(对称和不对称甲基及亚甲基中的O-H、C=O和C-H),但波数和吸光度切换到了高或低水平,突出了提取物与聚合物之间加合物/络合物的形成。X射线衍射(XRD)分析证实,所得制剂处于非晶相。原子力显微镜(AFM)分析强调了提取物-聚合物纳米制剂的形态学特性。可以注意到,在基于SE的制剂中,SE-PHB和SE-PLGA组合物的主要特征是形成了随机的大颗粒(SE-PHB)和较小的均匀颗粒(SE-PLGA);此外,在SE-PHB-PLGA的情况下,这些颗粒倾向于聚集。对于基于CE和GE的制剂,主要的表面形态是其孔隙率,通常具有小孔,但在某些情况下观察到较大的空洞(CE-和GE-PHB)。在(8 µm×8 μm)尺度下,粗糙度值最高的样品及顺序如下:CE-PHB < SE-PLGA < SE-PHB-PLGA。此外,通过热重分析评估了在压缩袜基质中的浸渍情况,其顺序如下:CE-聚合物>SE-聚合物>GE-聚合物。总之,制备了九种植物提取物-聚合物纳米制剂,并通过先进的物理化学方法进行了初步表征,作为进一步优化、稳定性研究以及可能用于复杂药物产品的起点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/e1654bde9827/polymers-16-01362-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/4e20f124d017/polymers-16-01362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/c78ea1f44647/polymers-16-01362-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/a9a1de967752/polymers-16-01362-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/d601343b430e/polymers-16-01362-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/24bfbf987a5a/polymers-16-01362-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/5e7376cb3343/polymers-16-01362-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/74dbbc622292/polymers-16-01362-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/e1654bde9827/polymers-16-01362-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/4e20f124d017/polymers-16-01362-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/c78ea1f44647/polymers-16-01362-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/a9a1de967752/polymers-16-01362-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/d601343b430e/polymers-16-01362-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/24bfbf987a5a/polymers-16-01362-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/5e7376cb3343/polymers-16-01362-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/74dbbc622292/polymers-16-01362-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dd6/11125073/e1654bde9827/polymers-16-01362-g008.jpg

相似文献

1
Preparation and Preliminary Analysis of Several Nanoformulations Based on Plant Extracts and Biodegradable Polymers as a Possible Application for Chronic Venous Disease Therapy.基于植物提取物和可生物降解聚合物的几种纳米制剂的制备及初步分析,作为慢性静脉疾病治疗的一种可能应用
Polymers (Basel). 2024 May 10;16(10):1362. doi: 10.3390/polym16101362.
2
Outlook on Chronic Venous Disease Treatment: Phytochemical Screening, In Vitro Antioxidant Activity and In Silico Studies for Three Vegetal Extracts.展望慢性静脉疾病的治疗:三种植物提取物的植物化学成分筛选、体外抗氧化活性和计算机模拟研究。
Molecules. 2023 Apr 23;28(9):3668. doi: 10.3390/molecules28093668.
3
Cytotoxicity Analysis and In Silico Studies of Three Plant Extracts with Potential Application in Treatment of Endothelial Dysfunction.三种植物提取物治疗内皮功能障碍的细胞毒性分析及计算机模拟研究
Pharmaceutics. 2023 Aug 11;15(8):2125. doi: 10.3390/pharmaceutics15082125.
4
Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.负载吲哚菁绿的可生物降解纳米颗粒:制备、理化特性及体外释放
Int J Pharm. 2004 Jul 8;278(2):293-301. doi: 10.1016/j.ijpharm.2004.03.032.
5
Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.微囊化方法和肽负载对聚乳酸和聚乳酸-乙醇酸共聚物体外测试期间降解的影响。
J Control Release. 1998 Feb 12;51(2-3):327-41. doi: 10.1016/s0168-3659(97)00188-0.
6
Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone.喷雾干燥型聚乳酸-羟基乙酸共聚物和聚乙烯吡咯烷酮可注射性聚合物基质的纳米级表面特性和混溶性研究。
J Pharm Sci. 2012 Sep;101(9):3473-85. doi: 10.1002/jps.23131. Epub 2012 Mar 23.
7
A Regenerative Polymer Blend Composed of Glycylglycine ethyl ester-substituted Polyphosphazene and Poly (lactic-co-glycolic acid).一种由甘氨酰甘氨酸乙酯取代的聚磷腈和聚(乳酸-乙醇酸共聚物)组成的再生聚合物共混物。
ACS Appl Polym Mater. 2020 Mar 13;2(3):1169-1179. doi: 10.1021/acsapm.9b00993. Epub 2020 Jan 8.
8
Preparation and physicochemical characterization of T-OA PLGA microspheres.T-OA PLGA 微球的制备及理化性质表征。
Chin J Nat Med. 2017 Dec;15(12):912-916. doi: 10.1016/S1875-5364(18)30007-4.
9
Levofloxacin loaded chitosan and poly-lactic-co-glycolic acid nano-particles against resistant bacteria: Synthesis, characterization and antibacterial activity.载左氧氟沙星壳聚糖和聚乳酸-共-羟基乙酸纳米粒子对抗耐药菌:合成、表征及抗菌活性。
J Infect Public Health. 2024 May;17(5):906-917. doi: 10.1016/j.jiph.2024.03.023. Epub 2024 Mar 22.
10
Characterization and Process Optimization for Enhanced Production of Polyhydroxybutyrate (PHB)-Based Biodegradable Polymer from Isolated from Municipal Solid Waste Landfill Site.从城市固体垃圾填埋场分离的用于提高聚羟基丁酸酯(PHB)基可生物降解聚合物产量的表征及工艺优化
Polymers (Basel). 2023 Mar 12;15(6):1407. doi: 10.3390/polym15061407.

引用本文的文献

1
Physicochemical Investigations on Samples Composed of a Mixture of Plant Extracts and Biopolymers in the Broad Context of Further Pharmaceutical Development.在进一步药物研发的广泛背景下,对由植物提取物和生物聚合物混合物组成的样品进行的物理化学研究。
Polymers (Basel). 2025 May 28;17(11):1499. doi: 10.3390/polym17111499.
2
Synergistic Effects of Green Nanoparticles on Antitumor Drug Efficacy in Hepatocellular Cancer.绿色纳米颗粒对肝癌抗肿瘤药物疗效的协同作用
Biomedicines. 2025 Mar 5;13(3):641. doi: 10.3390/biomedicines13030641.

本文引用的文献

1
The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II: Endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine.2023 年血管外科学会、美国静脉论坛和美国静脉与淋巴学会下肢静脉曲张管理临床实践指南。第二部分:得到介入放射学学会和血管医学学会的认可。
J Vasc Surg Venous Lymphat Disord. 2024 Jan;12(1):101670. doi: 10.1016/j.jvsv.2023.08.011. Epub 2023 Aug 29.
2
Outlook on Chronic Venous Disease Treatment: Phytochemical Screening, In Vitro Antioxidant Activity and In Silico Studies for Three Vegetal Extracts.展望慢性静脉疾病的治疗:三种植物提取物的植物化学成分筛选、体外抗氧化活性和计算机模拟研究。
Molecules. 2023 Apr 23;28(9):3668. doi: 10.3390/molecules28093668.
3
Improving Chronic Venous Disease Management with Micronised Purified Flavonoid Fraction: New Evidence from Clinical Trials to Real Life.改善慢性静脉疾病管理的微粉化纯化黄酮类化合物:来自临床试验到现实生活的新证据。
Clin Drug Investig. 2023 Jun;43(Suppl 1):9-13. doi: 10.1007/s40261-023-01261-y. Epub 2023 May 12.
4
Antiviral and antibacterial potential of electrosprayed PVA/PLGA nanoparticles loaded with chlorogenic acid for the management of coronavirus and lung infection.负载绿原酸的电喷雾聚乙烯醇/聚乳酸-羟基乙酸共聚物纳米颗粒对冠状病毒和肺部感染的抗病毒及抗菌潜力
Artif Cells Nanomed Biotechnol. 2023 Dec;51(1):255-267. doi: 10.1080/21691401.2023.2207606.
5
Optimising Decision Making in Chronic Venous Disease Management with Micronised Purified Flavonoid Fraction.采用微粉化纯化黄酮类混合物优化慢性静脉疾病的治疗决策。
Clin Drug Investig. 2023 Jun;43(Suppl 1):15-19. doi: 10.1007/s40261-023-01263-w. Epub 2023 Apr 21.
6
Naringin: Nanotechnological Strategies for Potential Pharmaceutical Applications.柚皮苷:潜在药物应用的纳米技术策略
Pharmaceutics. 2023 Mar 7;15(3):863. doi: 10.3390/pharmaceutics15030863.
7
High-Content Based Hydrogels: Physicochemical and Pharmaceutical Properties.基于高内涵的水凝胶:物理化学性质与药学性质
Polymers (Basel). 2023 Mar 6;15(5):1312. doi: 10.3390/polym15051312.
8
The Flavonoid Components of : Biopharmaceutical Properties and their Improvement using Nanoformulation Techniques.:类黄酮成分的生物制药特性及其纳米制剂技术的改善。
Curr Top Med Chem. 2023;23(1):17-29. doi: 10.2174/1568026623666221128144258.
9
Biomedical Applications of Plant Extract-Synthesized Silver Nanoparticles.植物提取物合成的银纳米粒子的生物医学应用
Biomedicines. 2022 Nov 2;10(11):2792. doi: 10.3390/biomedicines10112792.
10
In Vitro Anticancer Activity of Mucoadhesive Oral Films Loaded with (L.) F. H. Wigg Dry Acetone Extract, with Potential Applications in Oral Squamous Cell Carcinoma Complementary Therapy.负载(L.)F. H. Wigg干燥丙酮提取物的黏膜黏附口腔膜的体外抗癌活性及其在口腔鳞状细胞癌辅助治疗中的潜在应用
Antioxidants (Basel). 2022 Sep 28;11(10):1934. doi: 10.3390/antiox11101934.